CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Payments to Acquire Investments
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Payments to Acquire Investments of $11.80 million for the 6-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2026-08-05
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. payments to acquire investments for the quarter ending 2026-06-27 was $3.31M, a 18.83% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. payments to acquire investments for the quarter ending 2026-03-28 was $8.49M, a 60.17% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. payments to acquire investments for the quarter ending 2025-12-27 was $7.53M, a 1.05% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. payments to acquire investments for the quarter ending 2025-09-27 was $4.45M, a 54.21% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. payments to acquire investments for fiscal 2025 was $20.08M, a 62.03% decline from fiscal 2024.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. payments to acquire investments for fiscal 2024 was $52.88M, a 2.47% decline from fiscal 2023.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. payments to acquire investments for fiscal 2023 was $54.22M, a 65.75% decline from fiscal 2022.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. payments to acquire investments for fiscal 2022 was $158.27M, a 247.43% increase from fiscal 2021.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 6 month | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month |
|---|---|---|---|---|
| 2026-06-27 | $3.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $11.80M 10-Q · filed 2026-08-05 | $19.34M derived: sum of 3 quarters · filed 2026-08-05 | $23.79M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-28 | $8.49M 10-Q · filed 2026-05-07 | $16.02M derived: sum of 2 quarters · filed 2026-05-07 | $20.48M derived: sum of 3 quarters · filed 2026-05-07 | $23.27M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-27 | $7.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $11.99M derived: sum of 2 quarters · filed 2026-02-18 | $14.77M derived: sum of 3 quarters · filed 2026-08-05 | $20.08M 10-K · filed 2026-02-18 |
| 2025-09-27 | $4.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $7.24M derived: sum of 2 quarters · filed 2026-08-05 | $12.54M 10-Q · filed 2025-11-05 | $20.16M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-28 | $2.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $8.09M 10-Q · filed 2026-08-05 | $15.70M derived: sum of 3 quarters · filed 2026-08-05 | $25.43M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-29 | $5.30M 10-Q · filed 2026-05-07 | $12.91M derived: sum of 2 quarters · filed 2026-05-07 | $22.64M derived: sum of 3 quarters · filed 2026-05-07 | $44.31M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-28 | $7.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $17.34M derived: sum of 2 quarters · filed 2026-02-18 | $39.01M derived: sum of 3 quarters · filed 2026-02-18 | $52.88M 10-K · filed 2026-02-18 |
| 2024-09-28 | $9.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $31.40M derived: sum of 2 quarters · filed 2025-11-05 | $45.26M 10-Q · filed 2025-11-05 | $63.16M derived: sum of 4 quarters · filed 2026-02-18 |
| 2024-06-29 | $21.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $35.54M 10-Q · filed 2025-08-06 | $53.43M derived: sum of 3 quarters · filed 2026-02-18 | $67.06M derived: sum of 4 quarters · filed 2026-02-18 |
| 2024-03-30 | $13.87M 10-Q · filed 2025-05-07 | $31.76M derived: sum of 2 quarters · filed 2026-02-18 | $45.39M derived: sum of 3 quarters · filed 2026-02-18 | $55.51M derived: sum of 4 quarters · filed 2026-02-18 |
| 2023-12-30 | $17.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $31.53M derived: sum of 2 quarters · filed 2026-02-18 | $41.65M derived: sum of 3 quarters · filed 2026-02-18 | $54.22M 10-K · filed 2026-02-18 |
| 2023-09-30 | $13.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $23.75M derived: sum of 2 quarters · filed 2024-11-06 | $36.32M 10-Q · filed 2024-11-06 | $65.23M derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-07-01 | $10.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $22.69M 10-Q · filed 2024-08-07 | $51.60M derived: sum of 3 quarters · filed 2025-02-19 | $72.12M derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-04-01 | $12.57M 10-Q · filed 2024-05-09 | $41.48M derived: sum of 2 quarters · filed 2025-02-19 | $62.00M derived: sum of 3 quarters · filed 2025-02-19 | $157.55M derived: sum of 4 quarters · filed 2025-02-19 |
| 2022-12-31 | $28.91M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $49.43M derived: sum of 2 quarters · filed 2025-02-19 | $144.98M derived: sum of 3 quarters · filed 2025-02-19 | $158.27M 10-K · filed 2025-02-19 |
| 2022-09-24 | $20.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $116.07M derived: sum of 2 quarters · filed 2023-11-08 | $129.36M 10-Q · filed 2023-11-08 | $142.96M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-25 | $95.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $108.84M 10-Q · filed 2023-08-09 | $122.43M derived: sum of 3 quarters · filed 2024-02-14 | $131.13M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-26 | $13.30M 10-Q · filed 2023-05-11 | $26.89M derived: sum of 2 quarters · filed 2024-02-14 | $35.59M derived: sum of 3 quarters · filed 2024-02-14 | $42.30M derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-25 | $13.59M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $22.29M derived: sum of 2 quarters · filed 2024-02-14 | $29.00M derived: sum of 3 quarters · filed 2024-02-14 | $45.55M 10-K · filed 2024-02-14 |
| 2021-09-25 | $8.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $15.41M derived: sum of 2 quarters · filed 2022-11-02 | $31.96M 10-Q · filed 2022-11-02 | $38.77M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-26 | $6.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $23.27M 10-Q · filed 2022-08-03 | $30.07M derived: sum of 3 quarters · filed 2023-02-22 | $37.89M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-27 | $16.55M 10-Q · filed 2022-05-04 | $23.36M derived: sum of 2 quarters · filed 2023-02-22 | $31.18M derived: sum of 3 quarters · filed 2023-02-22 | $36.12M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-26 | $6.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $14.63M derived: sum of 2 quarters · filed 2023-02-22 | $19.57M derived: sum of 3 quarters · filed 2023-02-22 | $26.69M 10-K · filed 2023-02-22 |
| 2020-09-26 | $7.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $12.77M derived: sum of 2 quarters · filed 2021-11-03 | $19.89M 10-Q · filed 2021-11-03 | $24.56M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-27 | $4.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $12.06M 10-Q · filed 2021-08-04 | $16.74M derived: sum of 3 quarters · filed 2022-02-16 | $19.65M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-28 | $7.12M 10-Q · filed 2021-05-04 | $11.80M derived: sum of 2 quarters · filed 2022-02-16 | $14.71M derived: sum of 3 quarters · filed 2022-02-16 | $27.04M derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-28 | $4.68M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $7.59M derived: sum of 2 quarters · filed 2022-02-16 | $19.92M derived: sum of 3 quarters · filed 2022-02-16 | $22.34M 10-K · filed 2022-02-16 |
| 2019-09-28 | $2.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $15.24M derived: sum of 2 quarters · filed 2020-10-29 | $17.66M 10-Q · filed 2020-10-29 | $22.25M derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-06-29 | $12.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $14.75M 10-Q · filed 2020-08-05 | $19.34M derived: sum of 3 quarters · filed 2021-02-17 | $28.78M derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-03-30 | $2.42M 10-Q · filed 2020-05-07 | $7.01M derived: sum of 2 quarters · filed 2021-02-17 | $16.45M derived: sum of 3 quarters · filed 2021-02-17 | $22.28M derived: sum of 4 quarters · filed 2021-02-17 |
| 2018-12-29 | $4.59M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $14.03M derived: sum of 2 quarters · filed 2021-02-17 | $19.86M derived: sum of 3 quarters · filed 2021-02-17 | $25.13M 10-K · filed 2021-02-17 |
| 2018-09-29 | $9.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $15.27M derived: sum of 2 quarters · filed 2019-11-06 | $20.54M 10-Q · filed 2019-11-06 | $24.62M derived: sum of 4 quarters · filed 2020-02-11 |
| 2018-06-30 | $5.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $11.10M 10-Q · filed 2019-07-31 | $15.18M derived: sum of 3 quarters · filed 2020-02-11 | $27.34M derived: sum of 4 quarters · filed 2020-02-11 |
| 2018-03-31 | $5.27M 10-Q · filed 2019-05-07 | $9.35M derived: sum of 2 quarters · filed 2020-02-11 | $21.51M derived: sum of 3 quarters · filed 2020-02-11 | $44.79M derived: sum of 4 quarters · filed 2020-02-11 |
| 2017-12-30 | $4.08M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-11 | $16.24M derived: sum of 2 quarters · filed 2020-02-11 | $39.52M derived: sum of 3 quarters · filed 2020-02-11 | $46.22M 10-K · filed 2020-02-11 |
| 2017-09-30 | $12.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $35.44M derived: sum of 2 quarters · filed 2018-11-07 | $42.13M 10-Q · filed 2018-11-07 | |
| 2017-07-01 | $23.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $29.98M 10-Q · filed 2018-08-08 | ||
| 2017-04-01 | $6.70M 10-Q · filed 2018-05-10 | |||
| 2016-12-31 | $40.25M 10-K · filed 2019-02-13 | |||
| 2015-12-26 | $34.23M 10-K · filed 2018-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |